Jeff Weers
11Patents
10h-index
—Co-inventors
55Inventor score
Filing activity: Dec 5, 2006 → Dec 12, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8226975B2 | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof | Emerging Cross-Sectional Technologies | 41 | Active |
| US8673348B2 | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof | Emerging Cross-Sectional Technologies | 34 | Active |
| US8642075B2 | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof | Emerging Cross-Sectional Technologies | 34 | Active |
| US8673349B2 | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof | Emerging Cross-Sectional Technologies | 34 | Active |
| US8679532B2 | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof | Emerging Cross-Sectional Technologies | 30 | Active |
| US8632804B2 | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof | Emerging Cross-Sectional Technologies | 30 | Active |
| US9549939B2 | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof | Emerging Cross-Sectional Technologies | 29 | Active |
| US9402845B2 | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof | Emerging Cross-Sectional Technologies | 26 | Active |
| US9549925B2 | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof | Emerging Cross-Sectional Technologies | 22 | Active |
| US9511082B2 | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof | Emerging Cross-Sectional Technologies | 22 | Active |
| US10328071B2 | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof | Emerging Cross-Sectional Technologies | 10 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.